Researchers Deniz Çataklı
Deniz Çataklı profile image
Deniz Çataklı Res. Assist. SULEYMAN DEMIREL UNIVERSITY
Publication 7 Review 0
7 Publication
0 Review

Research Fields

Basic Pharmacology

Institution

SULEYMAN DEMIREL UNIVERSITY

Popular Publications

Caffeine May Improve the Chemotherapeutic Effect of Docetaxel by Inducing UPR and Autophagy in Breast Cancer Cells
Authors: Yalçın Erzurumlu , Deniz Çataklı , Hatice Kübra Doğan , Esra Aydoğdu
Published: 2023 , Fabad Journal of Pharmaceutical Sciences
DOI: 10.55262/fabadeczacilik.1164699
CITED 0 FAVORITE 1 TOTAL DOWNLOAD COUNT 207

0

1

207

Publications

Curcumin synergistically augments the chemotherapeutic activity of Doxorubicin in prostate cancer cells
Authors: Yalçın Erzurumlu , Deniz Çataklı , Hatice Kübra Doğan
Published: 2024 , Interdisciplinary Medical Journal
DOI: 10.17944/interdiscip.1297112
FAVORITE 0 TOTAL DOWNLOAD COUNT 111

0

111

CURCUMIN, THE BIOACTIVE COMPOUND OF TURMERIC, MAY IMPROVE THE ANTI-MALIGNANT PROPERTY OF GEMCITABINE IN PROSTATE CANCER CELLS
Authors: Yalçın Erzurumlu , Hatice Kübra Doğan , Deniz Çataklı
Published: 2023 , Journal of Faculty of Pharmacy of Ankara University
DOI: 10.33483/jfpau.1232868
FAVORITE 0 TOTAL DOWNLOAD COUNT 311

0

311

Investigation of Possible Synergistic Effects of Co-administration of Acetylsalicylic Acid and Salicylic Acid with Paclitaxel on Autophagy, ER stress and Apoptotic Cell Death in Prostate Cancer Cells
Authors: Yalçın Erzurumlu , Deniz Çataklı , Hatice Kübra Doğan
Published: 2023 , Suleyman Demirel University The Journal of Health Science
DOI: 10.22312/sdusbed.1206166
FAVORITE 0 TOTAL DOWNLOAD COUNT 502

0

502

Caffeine Potentiate the Anti-tumorigenic Effect of Cisplatin in Prostate Cancer Cells
Authors: Yalçın Erzurumlu , Deniz Çataklı , Hatice Kübra Doğan
Published: 2023 , CBU-SBED: Celal Bayar University-Health Sciences Institute Journal
DOI: 10.34087/cbusbed.1196678
FAVORITE 0 TOTAL DOWNLOAD COUNT 262

0

262

Caffeine May Improve the Chemotherapeutic Effect of Docetaxel by Inducing UPR and Autophagy in Breast Cancer Cells
Authors: Yalçın Erzurumlu , Deniz Çataklı , Hatice Kübra Doğan , Esra Aydoğdu
Published: 2023 , Fabad Journal of Pharmaceutical Sciences
DOI: 10.55262/fabadeczacilik.1164699
FAVORITE 1 TOTAL DOWNLOAD COUNT 207

1

207

INHIBITION OF IRE1α/XBP-1 BRANCH OF UPR BY GSK2850163 DRIVES THE SENSITIVITY TO TAMOXIFEN IN BREAST CANCER CELLS
Authors: Yalçın Erzurumlu , Hatice Kübra Doğan , Deniz Çataklı
Published: 2022 , Journal of Faculty of Pharmacy of Ankara University
DOI: 10.33483/jfpau.1129575
FAVORITE 0 TOTAL DOWNLOAD COUNT 267

0

267

A23187 May Improve Tamoxifen Sensitivity of Tamoxifen-Resistant Breast Cancer Cells
Authors: Yalçın Erzurumlu , Deniz Çataklı
Published: 2022 , CBU-SBED: Celal Bayar University-Health Sciences Institute Journal
DOI: 10.34087/cbusbed.1023372
FAVORITE 0 TOTAL DOWNLOAD COUNT 485

0

485

Articles published in
CBU-SBED: Celal Bayar University-Health Sciences Institute Journal
CBU-SBED: Celal Bayar University-Health Sciences Institute Journal
Fabad Journal of Pharmaceutical Sciences
Fabad Journal of Pharmaceutical Sciences
Interdisciplinary Medical Journal
Interdisciplinary Medical Journal
Journal of Faculty of Pharmacy of Ankara University
Journal of Faculty of Pharmacy of Ankara University
Suleyman Demirel University The Journal of Health Science
Suleyman Demirel University The Journal of Health Science
User doesn't have any peer review duties on DergiPark.
There are no Crossref cited.
Popular Publications: It is determined automatically by the researchers doing research in DergiPark according to the statistics of being added to the favorites. CrossRef Cited: The citations shown in DergiPark are drawn from CrossRef. For this, the cited and cited articles must be registered in CrossRef (DOI number). ^: Citation numbers are reflected in the system by DergiPark at certain periods.
Interactive Guide Tool
If you want to see the panel introduction, you can click Start Tour.